ZMYND12: A Potential Drug Target and Biomarker (G84217)
ZMYND12: A Potential Drug Target and Biomarker
Zinc finger MYND domain-containing protein 12 (ZMYND12) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZMYND12 is a transmembrane protein that is expressed in various tissues, including brain, pancreas, and muscle. Its unique structure, which consists of a zinc finger domain and a hydrophobic tail, has led to a high degree of homogeneity among its isoforms, making it a promising candidate for drug targeting.
The discovery of ZMYND12 as a potential drug target and biomarker began with its identification as a promising protein for drug targeting. ZMYND12 has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and protein stability. Its unique structure has also led to the prediction that it may have a unique mechanism of action, which could make it an attractive target for small molecules.
Further research has shown that ZMYND12 is involved in various signaling pathways, including the TGF-β pathway, which plays a crucial role in cell signaling and development. This pathway is known for its role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The TGF-β pathway is also involved in the regulation of cell growth, which is a known risk factor for cancer and other diseases.
In addition to its involvement in the TGF-β pathway, ZMYND12 has also been shown to be involved in the regulation of cell adhesion and migration. These processes are important for the development and progression of various diseases, including cancer.
The potential drug targeting of ZMYND12 also comes from its unique structure and the various functions it is involved in. ZMYND12 has been shown to interact with various signaling molecules, including TGF-β, NF-kappa-B, and SMAD. These molecules are involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation. By interacting with these molecules, ZMYND12 has been shown to play a role in the regulation of cellular processes that are important for the development and progression of various diseases.
In conclusion, ZMYND12 is a protein that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and the various functions it is involved in make it an attractive candidate for drug targeting. Further research is needed to fully understand its role in the development and progression of various diseases.
Protein Name: Zinc Finger MYND-type Containing 12
More Common Targets
ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257
